InvenireX-preview

Invenirex-co

InvenireX

Private

Newcastle upon TyneHealthcare & Life Scienceshttps://www.invenirex.co.uk/

Last Round

Seed

Nov 18, 2025

Total Funding Raised

$3.27M

Company Overview

InvenireX is a biotechnology company that develops an ultra-sensitive, real-time nucleic acid detection platform powered by DNA nanotechnology and artificial intelligence for use in molecular diagnostics and life sciences research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

nucleic acid detectionmolecular diagnosticsDNA nanotechnologyamplification-free detectionPCR alternativeAI-powered diagnosticsliquid biopsyearly disease detectionbenchtop instrumentlife sciences research toolsenzyme-free detectionmicrofluidic chipsreal-time quantificationinfectious disease diagnosticsvaccine quality control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InvenireX Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

InvenireX Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 18, 2025
Seed	Mar 18, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Dan Todd

Founder & CEO

Founding Team

InvenireX Investors

Notable investors and investment history

Investor	Rounds
Innovate UK	Seed
XTX Ventures	Seed
DSW Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 18, 2025
$2.6M raised led by DSW Ventures.
Nov 12, 2025
Grew 100% QoQ from 5 to 10 employees.

View all signals

InvenireX Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

InvenireX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InvenireX's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewcastle upon Tyne

Employee Range10

Year Founded2021

Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.